Former Synthes Execs Get Prison Time For Unauthorized Spine Trial
This article was originally published in The Gray Sheet
Federal authorities doled out prison time and fines to former executives of spinal fixation firm Synthes, and sent a broader warning to everyone in the industry about the penalties of corporate non-compliance for individuals.
You may also be interested in...
Appeals court affirms sentencing of executives who pled guilty to FDCA misdemeanor violations for distribution of salmonella-contaminated eggs; split ruling finds that officers don't need to know they were violating law to be subject to imprisonment.
International draft guidance on a single-audit program for device facilities is expected out by the end of the month, ECRI weighs in on UDI proposed rule, and more regulatory updates.
Despite the name, FDA’s “Pharmaceutical Fraud Pilot Program” includes devices in its mission. Of the 16 criminal investigations opened under the program last year, two are explicitly focused on device companies.